Browse by category

Diabetic weight-loss medications are effective for people with schizophrenia without affecting psychotic symptoms, according to...

Semaglutide is associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older...

Interim results from the ongoing Phase 2 COURAGE trial - investigating novel combinations of semaglutide (GLP-1 receptor agonist) and...

Researchers at the Sahlgrenska Academy at the University of Gothenburg have shown that it is possible to distinguish the nerve cells in...

Seventy-two week outcomes from the SURMOUNT-5 clinical trial have shown that tirzepatide (Zepbound) met the primary endpoint and all five...

Results from the ESSENCE Phase III clinical trial show treating patients with semaglutide can halt and even reverse liver disease, the...

Analysis of the SCORE and PRIDE studies shows semaglutide results in improved functional outcomes, health-related quality of life and CV...

Total weight loss did not increase for patients who took semaglutide before having BMS, suggesting that a surgery-first strategy could...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Semaglutide could also help people cut down on their alcohol intake, according to the findings from the ‘Human Laboratory Screening of...